Department of Hematology, Sultan Qaboos University Hospital, Muscat, Oman.
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico and Luigi Villa Foundation, Milan, Italy.
J Thromb Haemost. 2018 Jun;16(6):1052-1054. doi: 10.1111/jth.14126. Epub 2018 May 13.
Essentials Inherited factor XIII deficiency is a very rare bleeding disorder. We used recombinant factor XIII-A in a pregnant patient with factor XIII-A subunit deficiency. The patient had a successful pregnancy outcome with no pregnancy related complications. The dose of recombinant factor XIII-A was minimized by using frequent trough level monitoring.
Inherited factor XIII deficiency is a very rare bleeding disorder, and is one of the causes of recurrent pregnancy loss. The use of plasma-derived FXIII to improve pregnancy outcomes has been reported. We report a 26-year-old woman with FXIII A-subunit (FXIII-A) deficiency who was treated with recombinant FXIII-A and had a successful pregnancy outcome with no pregnancy-related complications. Our case illustrates that the dose of recombinant FXIII-A can be minimized and adjusted on the basis of frequent trough level monitoring.
遗传性因子 XIII 缺乏症是一种非常罕见的出血性疾病。我们在一名因子 XIII-A 亚单位缺陷的孕妇中使用了重组因子 XIII-A。该患者成功妊娠,无妊娠相关并发症。通过频繁的谷底水平监测,使重组因子 XIII-A 的剂量最小化。
遗传性因子 XIII 缺乏症是一种非常罕见的出血性疾病,也是复发性流产的原因之一。已报道使用血浆衍生的 FXIII 来改善妊娠结局。我们报告了一名 26 岁的女性,患有 FXIII A 亚单位(FXIII-A)缺乏症,接受了重组 FXIII-A 治疗,成功妊娠,无妊娠相关并发症。我们的病例表明,可以根据频繁的谷底水平监测来最小化和调整重组 FXIII-A 的剂量。